Crosstalk between the angiotensin and endothelin-system in the cerebrovasculature

Current Neurovascular Research

Volumn 10, Issue 4, 2013, Pages 335-345

  Konczalla, Juergen ^a   Wanderer, Stefan ^a   Mrosek, Jan ^a   Schuss, Patrick ^a   Platz, Johannes ^a   Güresir, Erdem ^a   Seifert, Volker ^a   Vatter, Hartmut ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Angiotensin; Cerebrovasculature; Crosstalk; Endothelin; ET(A) receptor; ET(B) receptor; Losartan

Indexed keywords

8 BROMO CYCLIC GMP; ANGIOTENSIN 1 RECEPTOR; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; LOSARTAN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NITRIC OXIDE; SARAFOTOXIN S6C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BRAIN INJURY; BRAIN VASOSPASM; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; UPREGULATION; VASOCONSTRICTION; VASODILATATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSINS; ANIMALS; BASILAR ARTERY; CELL COMMUNICATION; ENDOTHELIN-1; LOSARTAN; MALE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION; VASODILATION; VASOSPASM, INTRACRANIAL;

EID: 84888235009     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/15672026113109990030     Document Type: Article

References (70)

1. Kassell NF, Torner JC, Haley EC, Jr., Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990;73(1):18-36.
2. Vatter H, Konczalla J, Seifert V. Endothelin related pathophysiology in cerebral vasospasm: what happens to the cerebral vessels? Acta Neurochir Suppl 2011;110(Pt 1):177-80.
3. Salom JB, Torregrosa G, Alborch E. Endothelins and the cerebral circulation. Cerebrovasc Brain Metab Rev 1995;7(2):131-52.
4. Paczkowska E, Golab-Janowska M, Bajer-Czajkowska A, et al. Increased circulating endothelial progenitor cells in patients with haemorrhagic and ischaemic stroke: the role of Endothelin-1. J Neurol Sci 2013;325(1-2):90-9.
5. Konczalla J, Vatter H, Weidauer S, Raabe A, Seifert V. Alteration of the cerebrovascular function of endothelin B receptor after subarachnoidal hemorrhage in the rat. Exp Biol Med (Maywood) 2006;231(6):1064-8.
6. Kitazono T, Heistad DD, Faraci FM. Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo. J Pharmacol Exp Ther 1995;273(1):1-6.
7. Sun L, Zhang W, Wang X, Song J, Li M. Inhibition of protein kinase C signal reduces ET receptor expression and basilar vasospasm after subarachnoid hemorrhage in rats. J Integr Neurosci 2012;11(4):439-51.
8. Lanzino G, Kassell NF. Double-blind, randomized, vehiclecontrolled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 1999;90(6):1018-24.
9. Lanzino G, Kassell NF, Dorsch NW, et al. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 1999;90(6):1011-7.
10. Macdonald RL, Higashida RT, Keller E, et al. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocrit Care 2010;13(3):416-24.
11. Macdonald RL, Higashida RT, Keller E, et al. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2). Acta Neurochir Suppl 2013;115:27-31.
12. Ciurea A, Palade C, Voinescu D, Nica D. Subarachnoid hemorrhage and cerebral vasospasm-Literature review. J Med Life 2013;6(2):120-5.
13. Ansar S, Vikman P, Nielsen M, Edvinsson L. Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 2007;293(6):H3750- H3758.
14. Ansar S, Eftekhari S, Waldsee R, et al. MAPK signaling pathway regulates cerebrovascular receptor expression in human cerebral arteries. BMC Neurosci 2013;14:12.
15. Tirapelli CR, Bonaventura D, Tirapelli LF, de Oliveira AM. Mechanisms underlying the vascular actions of endothelin 1, angiotensin II and bradykinin in the rat carotid. Pharmacology 2009;84(2):111-26.
16. Dimitropoulou C, Chatterjee A, McCloud L, Yetik-Anacak G, Catravas JD. Angiotensin, bradykinin and the endothelium. Handb Exp Pharmacol 2006;(176 Pt 1):255-94.
17. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292(1):C82-C97.
18. Toda N, Miyazaki M. Angiotensin-induced relaxation in isolated dog renal and cerebral arteries. Am J Physiol 1981;240(2):H247-H254.
19. Yamaguchi K, Nishimura H. Angiotensin II-induced relaxation of fowl aorta. Am J Physiol 1988;255(4 Pt 2):R591-R599.
20. Tsutsumi Y, Matsubara H, Masaki H, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999;104(7):925-35.
21. Naveri L, Stromberg C, Saavedra JM. Angiotensin II AT1 receptor mediated contraction of the perfused rat cerebral artery. Neuroreport 1994;5(17):2278-80.
22. Tuor UI, Kondysar MH, Harding RK. Effect of angiotensin II and peptide YY on cerebral and circumventricular blood flow. Peptides 1988;9(1):141-9.
23. Smeda JS, Daneshtalab N. The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke. J Cereb Blood Flow Metab 2011;31(2):476-85.
24. Takada J, Ibayashi S, Ooboshi H, et al. Valsartan improves the lower limit of cerebral autoregulation in rats. Hypertens Res 2006;29(8):621-6.
25. Zhang R, Witkowski S, Fu Q, Claassen JA, Levine BD. Cerebral hemodynamics after short-and long-term reduction in blood pressure in mild and moderate hypertension. Hypertension 2007;49(5):1149-55.
26. Hong KS, Kang DW, Bae HJ, et al. Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial. Acta Neurol Scand 2010;121(1):51-7.
27. Schmerbach K, Schefe JH, Krikov M, et al. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain. Brain Res 2008;1208:225-33.
28. Chua BH, Chua CC, Diglio CA, Siu BB. Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1993;1178(2):201-6.
29. Dohi Y, Hahn AW, Boulanger CM, Buhler FR, Luscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992;19(2):131-7.
30. Kohno M, Horio T, Ikeda M, et al. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int 1992;42(4):860-6.
31. Maeso R, Rodrigo E, Munoz-Garcia R, et al. Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide. J Hypertens 1997;15(12 Pt 2):1677-84.
32. Engelhorn T, Goerike S, Doerfler A, et al. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 2004;24(4):467-74.
33. Saavedra JM, Benicky J, Zhou J. Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT(1) Receptor Antagonists in the Brain. Cell Mol Neurobiol 2006;26(7-8):1099-111.
34. Honda Y, Minato H, Fujitani B, Masuda Y, Hosoki K. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats. Methods Find Exp Clin Pharmacol 1997;19(10):699-706.
35. Provencio JJ. Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review. Acta Neurochir Suppl 2013;115:233-8.
36. Chen S, Ma Q, Krafft PR, et al. P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH. Neurobiol Dis 2013;58C:296-307.
37. Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH. Early Brain Injury, an Evolving Frontier in Subarachnoid Hemorrhage Research. Transl Stroke Res 2013;4(4):432-46.
38. Dreier JP, Drenckhahn C, Woitzik J, et al. Spreading ischemia after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2013;115:125-9.
39. Budohoski KP, Czosnyka M, Smielewski P, et al. Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study. Stroke 2012;43(12):3230-7.
40. Vatter H, Konczalla J, Seifert V. Endothelin related pathophysiology in cerebral vasospasm: what happens to the cerebral vessels? Acta Neurochir Suppl 2011;110(Pt 1):177-80.
41. Smeda JS, Daneshtalab N. The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke. J Cereb Blood Flow Metab 2011;31(2):476-85.
42. Rodrigues SF, Granger DN. Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide. J Cereb Blood Flow Metab 2012;32(2):368-75.
43. Guan W, Kozak A, El-Remessy AB, Johnson MH, Pillai BA, Fagan SC. Acute Treatment with Candesartan Reduces Early Injury After Permanent Middle Cerebral Artery Occlusion. Transl Stroke Res 2011;2(2):179-85.
44. Konczalla J, Mrosek J, Wanderer S, et al. Functional effects of levosimendan in rat basilar arteries in vitro. Curr Neurovasc Res 2013;10(2):126-33.
45. Vatter H, Weidauer S, Konczalla J, et al. Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model. Neurosurgery 2006;58(6):1190-7.
46. Vatter H, Konczalla J, Weidauer S, et al. Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm. Neurosurgery 2007;60(6):1100-8.
47. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA 1999;96(11):6506-10.
48. Israel A, Cierco M, Sosa B. Angiotensin AT(2) receptors mediate vasodepressor response to footshock in rats. Role of kinins, nitric oxide and prostaglandins. Eur J Pharmacol 2000;394(1):103-8.
49. Rasmussen R, Wetterslev J, Stavngaard T, et al. The effects of continuous prostacyclin infusion on regional blood flow and cerebral vasospasm following subarachnoid haemorrhage: study protocol for a randomised controlled trial. Trials 2012;13:102.
50. Gruetter CA, Ryan ET, Lemke SM, Bailly DA, Fox MK, Schoepp DD. Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur J Pharmacol 1988;146(1):85-95.
51. Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 1998;274(1 Pt 1):C214-C220.
52. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348(6303):730-2.
53. Nilsson T, Cantera L, Adner M, Edvinsson L. Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery 1997;40(2):346-51.
54. Vatter H, Weidauer S, Dias S, et al. Persistence of the nitric oxidedependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage. Neurosurgery 2007;60(1):179-87.
55. Cachofeiro V, Maeso R, Rodrigo E, Navarro J, Ruilope LM, Lahera V. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 1995;26(2):236-43.
56. Ma J, Kahwaji CI, Ni Z, Vaziri ND, Purdy RE. Effects of simulated microgravity on arterial nitric oxide synthase and nitrate and nitrite content. J Appl Physiol 2003;94(1):83-92.
57. Vaziri ND, Ding Y, Sangha DS, Purdy RE. Upregulation of NOS by simulated microgravity, potential cause of orthostatic intolerance. J Appl Physiol 2000;89(1):338-44.
58. Qadri F, Arens T, Schwartz EC, Hauser W, Dominiak P. Angiotensin- converting enzyme inhibitors and AT1-receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats. Jpn J Pharmacol 2001;85(4):365-9.
59. Stanarius A, Seidel B, Wolf G. Neuronal nitric oxide synthase in the vasculature of the rat brain: an immunocytochemical study using the tyramide signal amplification technique. J Neurocytol 1998;27(10):731-6.
60. De Kimpe SJ, Van Heuven-Nolsen D, van Amsterdam JG, Radomski MW, Nijkamp FP. Induction of nitric oxide release by interferon-gamma inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. J Pharmacol Exp Ther 1994;268(2):910-5.
61. Olmos L, Mombouli JV, Illiano S, Vanhoutte PM. cGMP mediates the desensitization to bradykinin in isolated canine coronary arteries. Am J Physiol 1995;268(2 Pt 2):H865-H870.
62. Zhang J, Van Meel JC, Pfaffendorf M, Zhang J, Van Zwieten PA. Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta. Eur J Pharmacol 1994;262(3):247-53.
63. Wiemer G, Scholkens BA, Wagner A, Heitsch H, Linz W. The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens Suppl 1993;11(5):S234-S235.
64. Baranov D, Armstead WM. Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles. Eur J Pharmacol 2005;525(1-3):112-6.
65. Knecht KR, Leffler CW. Distinct effects of intravascular and extravascular angiotensin II on cerebrovascular circulation of newborn pigs. Exp Biol Med (Maywood) 2010;235(12):1479-88.
66. Slaninka-Miceska M, Bogdanska J, Korneti P, Kostova E, Jovanoska E, Petrov S. Effect of angiotensin II type 1 (AT1) receptor antagonist on the endothelial dysfunction in spontaneously hypertensive rats in correlation with the nitric oxide system. Bratisl Lek Listy 2003;104(11):342-6.
67. Wilhelm I, Fazakas C, Krizbai IA. In vitro models of the bloodbrain barrier. Acta Neurobiol Exp (Wars) 2011;71(1):113-28.
68. Vikman P, Beg S, Khurana TS, Hansen-Schwartz J, Edvinsson L. Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J Neurosurg 2006;105(3):438-44.
69. Timaru-Kast R, Wyschkon S, Luh C, et al. Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma. Crit Care Med 2012;40(3):935-44.
70. Larysz-Brysz M, Lewin-Kowalik J, Czuba Z, et al. Interleukin-1beta increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage. Curr Neurovasc Res 2012;9(3):159-66.